BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 3.44 EUR -0.86% Market Closed
Market Cap: 75.2m EUR
Have any thoughts about
BRAIN Biotech AG?
Write Note

Wall Street
Price Targets

BNN Price Targets Summary
BRAIN Biotech AG

Wall Street analysts forecast BNN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNN is 7.23 EUR with a low forecast of 5.25 EUR and a high forecast of 10.5 EUR.

Lowest
Price Target
5.25 EUR
53% Upside
Average
Price Target
7.23 EUR
110% Upside
Highest
Price Target
10.5 EUR
205% Upside
BRAIN Biotech AG Competitors:
Price Targets
ADVENZYMES
Advanced Enzyme Technologies Ltd
9% Upside
300019
Chengdu Guibao Science & Technology Co Ltd
33% Upside
4958
T.Hasegawa Co Ltd
29% Upside
ASH
Ashland Global Holdings Inc
33% Upside
KWR
Quaker Chemical Corp
41% Upside
UZU
Uzin Utz AG
34% Upside
688550
XiAn Manareco New Materials Co Ltd
58% Upside

Revenue
Forecast

Revenue Estimate
BRAIN Biotech AG

For the last 8 years the compound annual growth rate for BRAIN Biotech AG's revenue is 11%. The projected CAGR for the next 4 years is 9%.

11%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BRAIN Biotech AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
BRAIN Biotech AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNN's stock price target?
Price Target
7.23 EUR

According to Wall Street analysts, the average 1-year price target for BNN is 7.23 EUR with a low forecast of 5.25 EUR and a high forecast of 10.5 EUR.

What is BRAIN Biotech AG's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for BRAIN Biotech AG's revenue is 11%. The projected CAGR for the next 4 years is 9%.

Back to Top